First Long Island Investors LLC Increased Its Stake in Abbott Labs Com (ABT) by $7.22 Million as Market Value Declined

January 23, 2018 - By Nellie Frank

Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It worsened, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. State Of Wisconsin Inv Board holds 2.58 million shares or 0.41% of its portfolio. Baystate Wealth Mngmt Ltd Llc reported 4,776 shares stake. South Dakota Investment Council accumulated 0.19% or 176,899 shares. Waters Parkerson & Limited Liability has invested 2.48% in Abbott Laboratories (NYSE:ABT). Rbf Capital Lc has invested 0.07% in Abbott Laboratories (NYSE:ABT). State Bank Hapoalim Bm owns 8,440 shares. Moreover, Guggenheim Cap Ltd Com has 0.12% invested in Abbott Laboratories (NYSE:ABT). Miller Howard Invs Inc New York stated it has 1.44M shares or 1.58% of all its holdings. Columbia Asset Mngmt holds 0.26% or 16,019 shares. 14,354 are owned by Nj State Employees Deferred Compensation Plan. Eubel Brady Suttman Asset Management Incorporated owns 0.15% invested in Abbott Laboratories (NYSE:ABT) for 8,917 shares. Davidson Investment holds 10,179 shares or 0.06% of its portfolio. The Delaware-based Lau Associates Limited Liability Corporation has invested 0.66% in Abbott Laboratories (NYSE:ABT). Teachers Ins & Annuity Association Of America has invested 0.32% in Abbott Laboratories (NYSE:ABT). Reik Com Ltd Liability has 5,215 shares for 0.09% of their portfolio.

Since August 1, 2017, it had 0 buys, and 6 insider sales for $22.86 million activity. 28,319 shares were sold by Salvadori Daniel Gesua Sive, worth $1.56M on Thursday, December 14. Shares for $2.74M were sold by Contreras Jaime on Friday, September 22. Another trade for 2,000 shares valued at $98,323 was made by Bracken Sharon J on Tuesday, August 1.

First Long Island Investors Llc increased its stake in Abbott Labs Com (ABT) by 48.18% based on its latest 2017Q3 regulatory filing with the SEC. First Long Island Investors Llc bought 136,242 shares as the company’s stock declined 3.42% while stock markets rallied. The hedge fund held 419,046 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $22.36 million, up from 282,804 at the end of the previous reported quarter. First Long Island Investors Llc who had been investing in Abbott Labs Com for a number of months, seems to be bullish on the $103.08 billion market cap company. The stock decreased 0.59% or $0.35 during the last trading session, reaching $59.22. About 5.69M shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 23, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: which released: “Abbott Labs Has ‘An Emerging Picture Of Top-Tier Growth,’ Says Morgan Stanley” on January 02, 2018, also with their article: “Medicare to cover new glucose monitor, giving Abbott an edge over rival Dexcom” published on January 04, 2018, published: “Abbott Laboratories expected to post earnings of 73 cents a share – summary” on January 22, 2018. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: and their article: “Narwhal Capital Management Buys UnitedHealth Group Inc, Abbott Laboratories …” published on January 23, 2018 as well as‘s news article titled: “Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories” with publication date: January 09, 2018.

Abbott Laboratories (NYSE:ABT) Ratings Coverage

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. Abbott Laboratories had 93 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Hold” on Monday, July 10. The stock of Abbott Laboratories (NYSE:ABT) earned “Market Perform” rating by BMO Capital Markets on Tuesday, March 14. The rating was maintained by Morgan Stanley with “Equal-Weight” on Thursday, October 19. Jefferies maintained Abbott Laboratories (NYSE:ABT) rating on Wednesday, October 18. Jefferies has “Buy” rating and $65.0 target. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Jefferies on Thursday, August 4. The company was maintained on Thursday, April 20 by Barclays Capital. As per Tuesday, January 2, the company rating was maintained by Guggenheim. The firm has “Buy” rating given on Thursday, October 19 by Stifel Nicolaus. On Monday, October 2 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm has “Equal-Weight” rating by Morgan Stanley given on Monday, January 4.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: